Literature DB >> 20385955

Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration.

Robin Casten, Barry W Rovner, Benjamin E Leiby, William Tasman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20385955     DOI： 10.1001/archophthalmol.2010.24

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  15 in total

1.  Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?

Authors:  Renu A Kowluru; Qing Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

2.  Improving function in age-related macular degeneration: design and methods of a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Robert W Massof; Benjamin E Leiby; William S Tasman
Journal:  Contemp Clin Trials       Date:  2010-10-23       Impact factor: 2.226

3.  Treatment satisfaction of patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor agents.

Authors:  Theodoros P Marakis; Chrysanthi Koutsandrea; Klio I Chatzistefanou; Yannis Tountas
Journal:  Int Ophthalmol       Date:  2017-03-11       Impact factor: 2.031

4.  Measurement of Perceived Stress in Age-Related Macular Degeneration.

Authors:  Bradley E Dougherty; San-San L Cooley; Frederick H Davidorf
Journal:  Optom Vis Sci       Date:  2017-03       Impact factor: 1.973

Review 5.  Update on depression and age-related macular degeneration.

Authors:  Robin J Casten; Barry W Rovner
Journal:  Curr Opin Ophthalmol       Date:  2013-05       Impact factor: 3.761

6.  Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Robert W Massof; Benjamin E Leiby; Allen C Ho; William S Tasman
Journal:  Ophthalmology       Date:  2014-07-09       Impact factor: 12.079

7.  Improving function in age-related macular degeneration: a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Robert W Massof; Benjamin E Leiby; Allen C Ho; William S Tasman
Journal:  Ophthalmology       Date:  2013-05-01       Impact factor: 12.079

Review 8.  The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study data.

Authors:  Sarah R Dawson; Christian D Mallen; Matthew B Gouldstone; Robert Yarham; Gemma Mansell
Journal:  BMC Ophthalmol       Date:  2014-06-12       Impact factor: 2.209

9.  Anxiety and depression in patients who receive anti-VEGF treatment and the usability and feasibility of e-mental health support: the E-PsEYE pilot study.

Authors:  Hilde Pa van der Aa; Ger Hmb van Rens; Frank D Verbraak; Machteld Bosscha; Hannie C Comijs; Ruth Ma van Nispen
Journal:  Ophthalmic Physiol Opt       Date:  2021-05-29       Impact factor: 3.117

Review 10.  Anxiety and depression in patients with advanced macular degeneration: current perspectives.

Authors:  Verena R Cimarolli; Robin J Casten; Barry W Rovner; Vera Heyl; Silvia Sörensen; Amy Horowitz
Journal:  Clin Ophthalmol       Date:  2015-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.